Skip to main content
. 2023 Jun 13;10(7):ofad315. doi: 10.1093/ofid/ofad315

Table 4.

Estimated Costs per Polymerase Chain Reaction–Confirmed Respiratory Syncytial Virus Hospitalization

Variable Mean Cost, CAD (95% CI)
Age, y
 50–59 (n = 44) $9340 ($6218–$12 461)
 60–64 (n = 43) $14 207 ($8651–$19 763)
 65–69 (n = 47) $19 786 ($9845–$29 727)
 70–79 (n = 92) $13 052 ($9037–$17 067)
 ≥80 (n = 145) $13 060 ($10 087–$16 033)
Provincea
 Alberta (n = 3) $9280 ($1894–$16 665)
 British Columbia (n = 16) $11 763 ($9034–$14 493)
 New Brunswick (n = 20) $7862 ($5812–$9913)
 Nova Scotia (n = 19) $13 204 ($9213–$171 194)
 Ontario (n = 274) $13 260 ($10 700–$15 821)
 Québec (n = 38) $20 291 ($11 513–$29 068)
 Overall (n = 371) $13 602 ($11 481–$15 723)

Abbreviations: CAD, Canadian dollars; CI, confidence interval.

a

Manitoba only reported 1 respiratory syncytial virus case; therefore, no cost was presented.